Yang Xu

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: ACTA DIABETOLOGICA. 2024;:1-10

Acute kidney injury events in patients with diabetes using sodium glucose transporter 2 inhibitors: a meta-analysis of cohort studies.

Shi Y; Dong S; Xu Y; Ji D; Yang L; Zhao R
Article: JOURNAL OF INTERNAL MEDICINE. 2023;294(5):628-639

Poor recognition and undertreatment of anemia in patients with chronic kidney disease managed in primary care.

Xu Y; Evans M; Mazhar F; Ärnlöv J; Cockburn E; Barany P; Carrero J-J
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2023;82(3):267-278

Long-term Visit-to-Visit Variability in Hemoglobin A1c and Kidney-Related Outcomes in Persons With Diabetes.

Xu Y; Dong S; Fu EL; Sjölander A; Grams ME; Selvin E; Carrero JJ
Article: CRITICAL CARE. 2023;27(1):84

National incidence and mortality of hospitalized sepsis in China.

Weng L; Xu Y; Yin P; Wang Y; Chen Y; Liu W; Li S; Peng J-M; Dong R; Hu X-Y; Jiang W; Wang C-Y; Gao P; Zhou M-G; Du B; China Critical Care Clinical Trials Group (CCCCTG)
Article: DIABETES CARE. 2022;45(12):2926-2934

Pharmacologic Treatment of Type 2 Diabetes in the U.S., Sweden, and Israel.

Lyu B; Sang Y; Selvin E; Chang AR; Alexander GC; Cohen CM; Coresh J; Shalev V; Chodick G; Karasik A; Carrero J-J; Fu EL; Xu Y; Grams ME; Shin J-I
Article: KIDNEY INTERNATIONAL. 2022;101(2):360-368

GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes.

Xu Y; Fu EL; Clase CM; Mazhar F; Jardine MJ; Carrero JJ
Article: AMERICAN HEART JOURNAL. 2022;243:177-186

Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes.

Xu Y; Fu EL; Trevisan M; Jernberg T; Sjölander A; Clase CM; Carrero J-J
Article: JOURNAL OF NEPHROLOGY. 2021;34(6):1949-1959

Burden and causes of hospital admissions and readmissions in patients undergoing hemodialysis and peritoneal dialysis: a nationwide study.

Xu Y; Li L; Evans M; Xu H; Lindholm B; Carrero JJ
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2021;23(10):1698-1707

Stopping mineralocorticoid receptor antagonists after hyperkalaemia: trial emulation in data from routine care.

Trevisan M; Fu EL; Xu Y; Savarese G; Dekker FW; Lund LH; Clase CM; Sjölander A; Carrero JJ
Article: CLINICAL KIDNEY JOURNAL. 2021;14(10):2213-2220

Secondary hyperparathyroidism and adverse health outcomes in adults with chronic kidney disease.

Xu Y; Evans M; Soro M; Barany P; Carrero JJ
Article: CLINICAL KIDNEY JOURNAL. 2021;14(7):1780-1788

Factors affecting pre-end-stage kidney disease haemoglobin control and outcomes following dialysis initiation: a nationwide study.

Xu Y; Evans M; Barany P; James G; Sjölander A; Carrero JJ
Article: DIABETES CARE. 2020;43(12):2975-2982

Glycemic Control and the Risk of Acute Kidney Injury in Patients With Type 2 Diabetes and Chronic Kidney Disease: Parallel Population-Based Cohort Studies in U.S. and Swedish Routine Care.

Xu Y; Surapaneni A; Alkas J; Evans M; Shin J-I; Selvin E; Chang A; Grams ME; Carrero JJ
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2020;35(9):1518-1526

Initiation of sodium polystyrene sulphonate and the risk of gastrointestinal adverse events in advanced chronic kidney disease: a nationwide study.

Laureati P; Xu Y; Trevisan M; Schalin L; Mariani I; Bellocco R; Sood MM; Barany P; Sjölander A; Evans M; Carrero JJ
Article: DIABETES OBESITY & METABOLISM. 2020;22(8):1425-1435

Association between reduced kidney function and incident hypoglycaemia in people with diabetes: The Stockholm Creatinine Measurements (SCREAM) project.

Runesson B; Xu Y; Qureshi AR; Lindholm B; Barany P; Elinder CG; Carrero JJ

Alla övriga publikationer

Letter: KIDNEY INTERNATIONAL. 2023;104(3):618-619

Routine care data and the benefits of GLP1 receptor agonists on slowing kidney function decline.

Xu Y; Faucon A-L; Fu EL; Carrero JJ
Review: CLINICAL KIDNEY JOURNAL. 2021;14(5):1307-1316

Pharmacoepidemiology for nephrologists (part 1): concept, applications and considerations for study design.

Trevisan M; Fu EL; Xu Y; Jager K; Zoccali C; Dekker FW; Carrero JJ
Review: CLINICAL KIDNEY JOURNAL. 2021;14(5):1317-1326

Pharmacoepidemiology for nephrologists (part 2): potential biases and how to overcome them.

Fu EL; van Diepen M; Xu Y; Trevisan M; Dekker FW; Zoccali C; Jager K; Carrero JJ

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI